Article
Targeting the RET pathway in thyroid cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Dec 2009
Wells Samuel A, Santoro Massimo
Abstract excerpt
The RET (rearranged during transfection) protooncogene encodes a single pass transmembrane receptor that is expressed in cells derived from the neural crest and the urogenital tract. As part of a cell-surface complex, RET binds glial derived neurotrophic factor (GDNF) ligands in conjunction with GDNF-family alpha co-receptors (GFRalpha). Ligand-induced activation induces dimerization and tyrosine phosphorylation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
